Gujarat, Ahmedabad 19 February 2025: Vaishali Pharma Ltd., a leading pharmaceutical company with a strong global presence, has acquired a 51% majority stake in Kesar Pharma Ltd by primary infusion. This strategic acquisition is set to enhance Vaishali Pharma’s market position, expand its manufacturing capabilities, and strengthen its supply chain through backward integration.
Strategic Rationale and Benefits
The acquisition aligns with Vaishali Pharma’s long-term growth strategy by adding Kesar Pharma’s well-established manufacturing facilities to its portfolio. By leveraging Kesar Pharma’s infrastructure and expertise, Vaishali Pharma will achieve enhanced production efficiency, cost optimization, and increased market penetration. This move will also ensure the full utilization of Kesar Pharma’ s existing resources, maximizing productivity and profitability.
With this acquisition, Vaishali Pharma gains a manufacturing facility that complies with WHO-GMP and other international regulatory guidelines. Notably, Kesar Pharma’s manufacturing facilities are approved by leading regulatory authorities in countries such as Nigeria, Kenya, Uganda, Congo, Ghana, Madagascar, Rwanda, Angola, Uzbekistan, Kyrgyzstan, Myanmar, the Philippines, and Cambodia. This approval underscores the high standards maintained by Kesar Pharma and further strengthens Vaishali Pharma’s global credibility.
Through this acquisition, Vaishali Pharma is eyeing a turnover of 300 crore in the next two years.
Advisory Partner
The acquisition was facilitated by Abans Financial Services Ltd. (Formerly Known as Abans Holdings Ltd), which provided strategic advisory services.
About Vaishali Pharma
Vaishali Pharma is a renowned pharmaceutical company specializing in the manufacturing and export of pharmaceutical formulations, active pharmaceutical ingredients (APIs), nutraceuticals, and herbal products. With a strong commitment to innovation and quality, the company adheres to stringent international standards and operates a robust distribution network across multiple countries. Its state-of-the-art manufacturing facilities comply with WHO-GMP regulations, ensuring excellence in production. Through its customer-centric approach, ethical business practices, and strategic global collaborations, Vaishali Pharma continues to grow steadily and make a positive impact on healthcare worldwide.
About Kesar Pharmaceuticals
Kesar Pharma is a well-respected pharmaceutical company engaged in the manufacturing and distribution of pharmaceutical formulations, APIs, and nutraceutical products. With a strong emphasis on innovation and research, the company follows global quality standards and ensures safety and efficacy through its WHO-GMP-compliant manufacturing facilities. Kesar Pharma’s expanding distribution network and commitment to ethical business practices have contributed to its growing presence in the pharmaceutical sector.
Leadership Perspectives
Speaking to the media, Atul Vasani, Chairman of Vaishali Pharma, stated, “This acquisition marks a significant milestone for both companies. By joining forces with Kesar Pharma, we aim to maximize the utilization of its advanced manufacturing facilities while maintaining the highest industry standards. This strategic move will allow us to scale our operations, enhance our global reach, and continue delivering high-quality, affordable healthcare solutions. We are confident that this partnership will create long-term value for our stakeholders and help us achieve our ambitious growth targets.”
Prakash Patel, Director of Kesar Pharma also shared his insights, saying, “This acquisition will ensure the best utilization of Kesar Pharma’s manufacturing facility while maintaining the highest quality standards. With Vaishali Pharma’s expertise and global network, we are poised to scale up production and expand our market footprint. We are excited about the opportunities this partnership brings and look forward to a successful collaboration that benefits both companies and the healthcare sector as a whole.”
This acquisition represents a major step toward Vaishali Pharma’s continued growth and commitment to improving healthcare accessibility and patient outcomes worldwide.
